Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion-Reference-Cited by-同舟云学术

Sphingomimetic multiple sclerosis drug FTY720 activates vesicular synaptobrevin and augments neuroendocrine secretion

Published:2017-07-20 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Darios Frederic D.,Jorgacevski Jernej^ORCID,Flašker Ajda,Zorec Robert,García-Martinez Virginia,Villanueva José,Gutiérrez Luis M.,Leese Charlotte,Bal Manjot,Nosyreva Elena,Kavalali Ege T.,Davletov Bazbek

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-05948-z.pdf

Reference52 articles.

1. Brunkhorst, R., Vutukuri, R. & Pfeilschifter, W. Fingolimod for the treatment of neurological diseases-state of play and future perspectives. Front Cell Neurosci 8, 283 (2014).

2. Davletov, B. & Montecucco, C. Lipid function at synapses. Curr Opin Neurobiol 20, 543–549 (2010).

3. Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nat Rev Mol Cell Biol 9, 139–150 (2008).

4. He, X., Huang, Y., Li, B., Gong, C. X. & Schuchman, E. H. Deregulation of sphingolipid metabolism in Alzheimer’s disease. Neurobiol Aging 31, 398–408 (2010).

5. O’Connor, P. et al. Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. Neurology 72, 73–79 (2009).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720;Cells;2023-09-24

2. Vesicle Fusion as a Target Process for the Action of Sphingosine and Its Derived Drugs;International Journal of Molecular Sciences;2022-01-19

3. Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2022-01

4. FTY720 (Fingolimod), a modulator of sphingosine-1-phosphate receptors, increases baseline hypothalamic-pituitary adrenal axis activity and alters behaviors relevant to affect and anxiety;Physiology & Behavior;2021-10